Harmony Biosciences has paused a mid-stage trial of ZYN002 in 22q11.2 deletion syndrome after the THC-free cannabinoid drug ...

Harmony also touts late-stage asset EPX-100 (clemizole hydrochloride), which the biotech is running through a pair of phase 3 trials in Dravet syndrome and Lennox-Gastaut Syndrome— both rare forms of ...

New York, Dec. 11, 2023 (GLOBE NEWSWIRE) -- According to the market.us, the global Cannabidiol Market Size was valued at USD 7.6 billion in 2023 and is anticipated to reach approximately USD 36.6 ...

New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cannabidiol Global Market Report 2023" - https://www.reportlinker ...

Please provide your email address to receive an email when new articles are posted on . Survey responses reflected positive language and communication outcomes after cannabidiol use. Further ...

Cannabidiol may halve the severity of chronic anxiety symptoms and impairment in young people, an Orygen pilot study has shown Cannabidiol may be effective in halving the severity of symptoms and ...

Researchers from the University of Rochester and Harvard Medical School developed a nano-micelle CBD formulation that rapidly ...

Video shows mice that have been exposed to cannabidiol during gestation tracked with technology that uses infra-red, depth-sensing cameras and machine learning (or artificial intelligence, AI) called ...

A new study has found that, contrary to expectations, pre-treatment with cannabidiol, or CBD, exacerbated the acute memory ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window HOUSTON -- ...

Escambia County received a development proposal to create a smoke shop that will sell cannabidiol (CBD) and hemp-based ...